Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting

American Journal of Cardiology

Volumn 113, Issue 3, 2014, Pages 565-569

  Dinicolantonio, James J ^a   Beavers, Craig J ^b   Menezes, Arthur R ^c   Lavie, Carl J ^c,d   O'Keefe, James H ^a   Meier, Pascal ^e   Vorobcsuk, András ^f   Aradi, Dániel ^f,l   Komócsi, András ^f   Chatterjee, Saurav ^g   D'Ascenzo, Fabrizio ^h   Gasparini, Mauro ⁱ   Brugts, Jasper ^j   Biondi Zoccai, Giuseppe ^k  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b CENTENNIAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^f UNIVERSITY OF PÉCS   (Hungary)

^g ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^h MOLINETTE HOSPITAL   (Italy)

ⁱ POLITECNICO DI TORINO   (Italy)

^j ERASMUS MEDICAL CENTER   (Netherlands)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

^l Department of Cardiology   (Hungary)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; METOPROLOL;

ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARBAZOLES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HUMANS; METOPROLOL; POSTOPERATIVE PERIOD; PROPANOLAMINES; TREATMENT OUTCOME;

EID: 84892601604     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.10.020     Document Type: Review

References (15)

1. K.A. Eagle, R.A. Guyton, R. Davidoff, F.H. Edwards, G.A. Ewy, T.J. Gardner, J.C. Hart, H.C. Herrmann, L.D. Hillis, A.M. Hutter Jr., B.W. Lytle, R.A. Marlow, W.C. Nugent, T.A. Orszulak, American College of Cardiology, and American Heart Association ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1999 guidelines for coronary artery bypass graft surgery) Circ 110 2004 e340 e437
2. D. Bradley, L.L. Creswell, C.W. Hogue Jr., A.E. Epstein, E.N. Prystowsky, and E.G. Daoud Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 2005 39 47
3. M.R. Bristow, R. Ginsburg, V. Umans, M. Fowler, W. Minobe, R. Rasmussen, P. Zera, R. Menlove, P. Shah, and S. Jamieson Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure Circ Res 59 1986 297 309
4. S. Motomura, N.M. Deighton, H.R. Zerkowski, N. Doetsch, M.C. Michel, and O.E. Brodde Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium Br J Pharmacol 101 1990 363 369
5. M. Arumanayagam, S. Chan, S. Tong, and J.E. Sanderson Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trial J Cardiovasc Pharmacol 37 2001 48 54
6. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, J.P. Ioannidis, M. Clarke, P.J. Devereaux, J. Kleijnen, and D. Moher The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 6 2009 1 28
7. J.P. Higgins, and S. Green Assessing Risk of Bias in Included Studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 Edn 2008 The Cochrane Collaboration Oxford 633
8. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
9. M. Haghjoo, M. Saravi, M.J. Hashemi, S. Hosseini, N. Givtaj, M.H. Ghafarinejad, A.J. Khamoushi, Z. Emkanjoo, A.F. Fazelifar, A. Alizadeh, and M.A. Sadr-Ameli Optimal B-blocker for the prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol Heart Rhythm 4 2007 1170 1174
10. S. Acikel, H. Bozbas, B. Gultekin, A. Aydinalp, B. Saritas, U. Bal, A. Yildirir, H. Muderrisoglu, A. Sezgin, and B. Ozin Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary artery bypass surgery Int J Cardiol 126 2008 108 113
11. M. Ozaydin, A. Icli, H. Yucel, S. Akcay, O. Peker, D. Erdogan, E. Varol, A. Dogan, and H. Okutan Metoprolol versus carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study Eur Heart J 34 2013 597 604
12. M. Shahzamani, A. Ghanavati, A.N. Froutagheh, M. Foroughi, H. Rahimian, A. Shahsanaei, S.A. Hasantash, and A. Dabbagh Carvedilol compared with metoprolol on left ventricular ejection fraction after coronary artery bypass graft J Perianesth Nurs 26 2011 384 387
13. H.J. Dargie Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
14. J.J. DiNicolantonio, and D.G. Hackam Carvedilol: a third-generation B-blocker should be a first-choice B-blocker Expert Rev Cardiovasc Ther 10 2012 13 25
15. C. Torp-Pedersen, P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, B. Lutiger, M. Metra, W.J. Remme, A. Scherhag, A. Skene COMET Investigators Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure - COMET Am Heart J 149 2005 370 376